In this issue:
DNA methylation signatures for predicting biologic response in CD
Epidemiology and steroid dependency in CD during the biologics era
Anxiety/depression at IBD diagnosis
Trends in colectomy rates and advanced therapy prescribing in Scotland
Maintenance azathioprine or tofacitinib in corticosteroid-responsive acute severe UC
Pain and sedative medication use among individuals with IBD
Infliximab and adalimumab for fistulising CD
Healthcare utilisation by children born to women with vs. without IBD
Active IBD and risks of adverse pregnancy and neonatal outcomes
Guselkumab in East Asians with moderate-to-severe UC in QUASAR trials
Please login below to download this issue (PDF)